Preventing acute asthmatic symptoms by targeting a neuronal mechanism involving carotid body lysophosphatidic acid receptors
Acute bronchoconstriction is the leading cause of asthmatic sudden death following allergen exposure. The authors show that the systemic increase of LPA following inhaled allergen or bradykinin challenge activates the carotid bodies through TRPV1 and LPA-specific receptors and that systemic TRPV1 an...
Guardado en:
Autores principales: | Nicholas G. Jendzjowsky, Arijit Roy, Nicole O. Barioni, Margaret M. Kelly, Francis H. Y. Green, Christopher N. Wyatt, Richard L. Pye, Luana Tenorio-Lopes, Richard J. A. Wilson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b65eae4fc874352ad6f95844a3997d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
THE CORRELATION OF SYMPTOMS AND OBJECTIVE WHEEZE IN ASTHMATICS
por: Abdul Latif Khattak, et al.
Publicado: (2020) -
THE CORRELATION OF SYMPTOMS AND OBJECTIVE WHEEZE IN ASTHMATICS
por: Abdul Latif Khattak, et al.
Publicado: (2020) -
2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Keiko Fukasawa, et al.
Publicado: (2021) -
Physiotherapy in the treatment of the asthmatic and emphysematous patient
por: Margaret R. White
Publicado: (1960) -
Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?
por: Thomas Duflot, et al.
Publicado: (2021)